Desperate patients want a new ALS drug. The FDA is not sure it works.
Today, those former students run the Cambridge-based biotech company Amylyx that is seeking Food and Drug Administration approval for the treatment, known as AMX0035. And Kowalski and other ALS patients are flooding the federal agency …
See Original Article
Law360 MVP Awards: Eight Sullivan & Cromwell Partners Named 2022 MVPs
Eight Sullivan & Cromwell partners have been named Law360 MVPs for âsecuring hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.â The Sullivan & Cromwell lawyers were selected from more than 900Â …
See Original Article

Leave a Reply